NCT05337293

Brief Summary

The purpose of this study is to examine the feasibility and preliminary effectiveness of a 12-week support and problem-solving telephone-based intervention (COPE-HF) on heart failure self-care, depression, and healthcare utilization. Heart failure patients will be randomized to one of three groups (intervention, attention, control), with data collected at baseline and at 5, 9, and 13 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
Completed

Started Mar 2015

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
5.7 years until next milestone

First Submitted

Initial submission to the registry

April 13, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2022

Completed
Last Updated

March 21, 2023

Status Verified

March 1, 2023

Enrollment Period

1.4 years

First QC Date

April 13, 2022

Last Update Submit

March 20, 2023

Conditions

Keywords

heart failureproblem-solvingsocial supportself-care

Outcome Measures

Primary Outcomes (9)

  • Self-care Maintenance

    Self-care maintenance was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to treatment adherence and self-monitoring. Scores are standardized (0-100), with higher scores suggesting better self-care maintenance. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 5 weeks

  • Self-care Maintenance

    Self-care maintenance was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to treatment adherence and self-monitoring. Scores are standardized (0-100), with higher scores suggesting better self-care maintenance. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 9 weeks

  • Self-care Maintenance

    Self-care maintenance was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to treatment adherence and self-monitoring. Scores are standardized (0-100), with higher scores suggesting better self-care maintenance. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 13 weeks

  • Self-care Management

    Self-care management was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting better self-care management. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 5 weeks

  • Self-care Management

    Self-care management was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting better self-care management. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 9 weeks

  • Self-care Management

    Self-care management was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to symptom recognition and treatment and evaluation of treatment effectiveness. Scores are standardized (0-100), with higher scores suggesting better self-care management. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 13 weeks

  • Self-care Confidence

    Self-care confidence was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to one's confidence in their ability to perform self-care activities. Scores are standardized (0-100), with higher scores suggesting better self-care confidence. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 5 weeks

  • Self-care Confidence

    Self-care confidence was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to one's confidence in their ability to perform self-care activities. Scores are standardized (0-100), with higher scores suggesting better self-care confidence. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 9 weeks

  • Self-care Confidence

    Self-care confidence was self-reported and measured using the Self-care of Heart Failure Index (SCHFI) v. 6.2. Items pertain to one's confidence in their ability to perform self-care activities. Scores are standardized (0-100), with higher scores suggesting better self-care confidence. Scores ≥ 70 are considered adequate, with an improvement of 8 or more considered clinically significant.

    baseline, 13 weeks

Secondary Outcomes (6)

  • Depression

    baseline, 5 weeks

  • Depression

    baseline, 9 weeks

  • Depression

    baseline, 13 weeks

  • Healthcare utilization

    baseline, 5 weeks

  • Healthcare utilization

    baseline, 9 weeks

  • +1 more secondary outcomes

Other Outcomes (9)

  • Heart Failure Symptoms

    baseline, 5 weeks

  • Heart Failure Symptoms

    baseline, 9 weeks

  • Heart Failure Symptoms

    baseline, 13 weeks

  • +6 more other outcomes

Study Arms (3)

COPE-HF Partnership Intervention

EXPERIMENTAL

Working with a trained registered nurse interventionist, participants in this arm were trained to use a 4-step problem-solving process to manage identified problems related to heart failure. Heart failure self-care education and materials were provided as indicated based on specific identified problems.

Behavioral: COPE-HF Partnership Intervention

Attention

SHAM COMPARATOR

Participants in this arm received telephone calls from a trained research assistant on the same schedule as the intervention group. During these calls basic data were collected on several key areas of heart failure self-care. No intervention or patient education took place during these calls.

Other: Attention

Usual Care

NO INTERVENTION

Participants in this arm received usual care from their healthcare providers and facility designated heart failure discharge education only.

Interventions

Participants were trained to use a 4-step problem-solving process based on the Theory of Social Problem-Solving (TSPS) to manage HF-related problems experienced in the home over 12-weeks. The core belief of TSPS is effective problem-solving requires a positive problem orientation (i.e., viewing problems as a challenge versus a threat) and elicits rational problem-solving versus avoidance or impulsivity/carelessness. Problem-solving follows from a positive problem orientation and involves accurate problem identification, generation of appropriate potential solutions, active decision-making, and solution implementation and evaluation. The goal of this intervention was to move HF patients toward a positive problem orientation and use of rational problem-solving strategies that support greater HF self-care and reduce depression. The COPE-HF Partnership Intervention consisted of 1 home visit and 7 follow-up telehealth sessions led by a registered nurse interventionist.

COPE-HF Partnership Intervention

Participants in the attention group received a sham intervention that consisted of scheduled telephone calls consistent with the timing of that received by the intervention group. During these calls, basic information was gathered on key areas of heart failure self-care management and the frequency of healthcare usage. No intervention or education was provided.

Attention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized with a primary or secondary diagnosis of HF
  • Undergoing medical treatment for HF
  • BNP \>100
  • Able to read, speak, and understand English
  • Reliable telephone access
  • Live within 100 miles of acute care facility

You may not qualify if:

  • Diagnosis of heart failure due to a correctable cause or condition
  • Reduced life expectancy \< 12 months
  • History of cognitive impairment or a score \>8 on the 6CIT
  • Inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Capital Regional Medical Center

Tallahassee, Florida, 32308, United States

Location

Tallahassee Memorial Hospital

Tallahassee, Florida, 32308, United States

Location

MeSH Terms

Conditions

Heart Failure

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Lucinda J Graven, PhD APRN

    Florida State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All data were collected by a research assistant blinded to study group assignment and purpose of study. A second research assist blinded to study purpose and intervention conducted all participant contacts with the attention group.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This parallel 3-arm (intervention, attention, control) randomized controlled trial (N = 90) will concurrently enroll patients with heart failure to either a 12-week intervention (COPE-HF Partnership), a 12-week attention group (contacts spaced similarly to that of the intervention group), or a control group. All data collection contacts occur at identical intervals among groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 13, 2022

First Posted

April 20, 2022

Study Start

March 1, 2015

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

March 21, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

No IPD will be shared with other researchers.

Locations